跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-ESOMEPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-ESOMEPRAZOLE
Authorized
STANDARD
M-ESOMEPRAZOLE
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b7f2215e0da8e5b1
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
b7f2215e0da8e5b1
Drug Approval Canada Name
M-ESOMEPRAZOLE
Product Name
M-ESOMEPRAZOLE
Status
Marketed
Status Date
2022-03-16
Original Market Date
2022-03-16
Din
02520109
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC05 ESOMEPRAZOLE
Atc Name
a 02 bc 05
Aig Number
0145162001
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b7f2215e0da8e5b1
Type
Standard
Back to Health Canada Approvals